EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease

Woojin Ahn, Seoyoon Choi, So Jung Han, Soo Jung Park, Jae Jun Park, Tae Il Kim, Jihye Park, Jae Hee Cheon

Intestinal Research · 31.10.2026 · 24 (4) · 735-743

DOI: 10.5217/ir.2025.00267 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Intestinal Research, erschienen am 31.10.2026. Verfasst von Woojin Ahn und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Aims: Intestinal Behçet’s disease (BD) is a manifestation of BD involving the gastrointestinal tract. Although fecal calprotectin (FC) is a useful inflammatory marker, its role in intestinal BD is unclear.

Methods

We retrospectively analyzed 78 patients with intestinal BD to evaluate correlations between FC levels and the Disease Activity Index for Intestinal Behçet’s Disease (DAIBD), C-reactive protein (CRP), and erythrocyte sedimentation rate. FC and CRP levels were compared between patients in endoscopic remission and those with active disease. Receiver operating characteristic (ROC) curve analysis was used to evaluate FC’s ability to predict endoscopic activity and ulcer size.

Results

FC levels significantly correlated with DAIBD scores (r= 0.253, P= 0.025) and CRP (r= 0.227, P= 0.046). Patients with endoscopically active disease had higher FC (1,124 ± 1,957 μg/g vs. 367 ± 1,208 μg/g; P< 0.001) and CRP levels (16.0 ± 23.7 mg/L vs. 14.4 ± 46.5 mg/L; P= 0.027) than those in remission. Patients with larger ulcers ( ≥ 30 mm) had higher FC levels than those with smaller ulcers (2,212 ± 2,609 μg/g vs. 962 ± 1,822 μg/g; P= 0.034). An FC cutoff level of 176 μg/g discriminated active endoscopic disease (sensitivity 59.3%, specificity 83.3%), with an area under the ROC curve (AUC) of 0.724 (95% confidence interval, 0.605–0.843; P= 0.002), outperforming CRP (AUC, 0.657).

Conclusions

FC levels correlated with DAIBD scores and endoscopic inflammation in intestinal BD. FC outperformed CRP in detecting endoscopic activity, supporting its use in disease management.

Schlagwörter

Stichwörter der Autor:innen

Behcet syndromeBiomarkersGastrointestinal diseasesInflammationLeukocyte L1 antigen complex

Autor:innen und Institutionen

  • Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Institute of Gastroenterology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
  • Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. wisdompark@yuhs.ac.
  • Institute of Gastroenterology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. wisdompark@yuhs.ac.
  • Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. geniushee@yuhs.ac.
  • Institute of Gastroenterology, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. geniushee@yuhs.ac.

Zitieren

APA

Ahn, W., Choi, S., Han, S. J., Park, S. J., Park, J. J., Kim, T. I., Park, J., & Cheon, J. H. (2026). Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease. Intestinal Research, 24(4), 735-743. https://doi.org/10.5217/ir.2025.00267

Vancouver

Ahn W, Choi S, Han SJ, Park SJ, Park JJ, Kim TI, et al. Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease. Intestinal Research. 2026;24(4):735-743. doi:10.5217/ir.2025.00267

BibTeX
@article{Ahn2026,
  author = {Ahn, Woojin and Choi, Seoyoon and Han, So Jung and Park, Soo Jung and Park, Jae Jun and Kim, Tae Il and Park, Jihye and Cheon, Jae Hee},
  title = {Clinical usefulness of fecal calprotectin in assessing disease activity and endoscopic remission in intestinal Behçet’s disease},
  journal = {Intestinal Research},
  year = {2026},
  volume = {24},
  number = {4},
  pages = {735--743},
  doi = {10.5217/ir.2025.00267}
}
Kostenlos starten →